GlassScriptPhysician profile
Christina Macdowell
NPI 1497269138
$1,127.00
in general payments reported to CMS, 2019-2025
18 companies · $562 in 2025
The $562 reported for 2025 was more than what 81% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $88.01 · 2023: $279 · 2024: $198 · 2025: $562.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,039.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,038.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sage Therapeutics, LLC | $314.46 | 2024-2025 | Zurzuvae |
| Abbvie INC. | $129.27 | 2022-2025 | |
| Lilly USA, LLC | $125.00 | 2025 | Zepbound |
| Bayer Healthcare Pharmaceuticals INC. | $105.62 | 2023-2025 | |
| Organon LLC | $91.58 | 2022-2025 | Nexplanon |
| Shield Therapeutics INC | $49.30 | 2023 | Accrufer |
| Axonics, INC. | $48.98 | 2023 | Axonics, Bulkamid |
| Pfizer INC. | $46.41 | 2023-2024 | |
| Sumitomo Pharma America, INC. | $30.41 | 2025 | Myfembree, Gemtesa |
| Millicent US INC | $28.35 | 2025 | Intrarosa, Femlyv |
| Astellas Pharma US INC | $26.70 | 2024 | Veozah |
| Hologic Sales and Service, LLC | $23.23 | 2024 | Myosure Tissue Removal Device, Fluent Fluid Management System |
| Daiichi Sankyo INC. | $19.54 | 2023 | Injectafer |
| Mayne Pharma Commercial LLC | $19.41 | 2023 | |
| Supernus Pharmaceuticals, INC. | $18.17 | 2025 | Qelbree |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $17.51 | 2023 | |
| Amgen INC. | $17.15 | 2025 | Evenity |
| Exeltis, USA INC. | $15.91 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christina Macdowell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.